Introduction
In routine clinical trials, the introduction of 18 FDG-PET/CT has lead to a significant improvement in diagnostic accuracy and exerted a considerable impact on patient management including detecting the primary and metastatic tumors, staging, restaging, therapy monitoring, optimization of treatment, follow up of the efficacy of the treatment and prognosis prediction of different malignant tumors (Vallabhajosula, 2007; Kitajima et al., 2011) . 18 FDG is the most commonly used PET tumor diagnostic radiotracer that allows visualization of the changes in the glucose metabolic rate in tumors (Wahl, 1996; Weber, 2005; Kitajima et al., 2011 (Wahl, 1996; Southworth et al., 2003; Ong et al., 2008) .
Pgp mediated multidrug resistance (MDR) seems to be the most widely observed mechanism in clinical cases of chemotherapy resistance and is known to protect the different tissues from a variety of exogenous and endogenous substances (Goda et al., 2009; Breier et al., 2013) . Generally, Pgp substrates are organic amphipathic molecules ranging in size from about 200 to almost 1900 Daltons. The first identified Pgp substrates were chemotherapeutic drugs used in cancer chemotherapy, such a taxanes, anthracyclines, vinca alkaloids. However, many commonly prescribed drugs from various chemical and pharmacological classes are now known to be Pgp substrates (Endres et al., 2006; Eyal et al., 2009) . Consequently, the detection of Pgp expression as well as overcoming the Pgp mediated active efflux of chemotherapeutic drugs from the tumor cells are important prerequisites of successful chemotherapy.
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Positron emission tomography (PET) and single-photon emission tomography (SPECT) seems to be the most useful methods to study multidrug resistance in tumour tissues in vivo (Mairinger et al., 2011 (Lorke et al., 2001; Higashi et al., 2004; Yamada et al., 2005; Seo et al., 2009; Smith, 2010; Yu et al., 2012) . It was also reported that certain Pgp modulators e.g. verapamil or cepharanthine restored the uptake of 18 FDG and this finding was interpreted to suggest that 18 FDG might be a substrate of Pgp (Seo et al., 2009 ). In contrary with the above observations, we measured higher 18 FDG uptake in the Pgp + cells compared to their Pgp -counterpart in case of the A2780/A2780AD and KB-3-1/KB-V-1 human gynecologic cancer cell pairs (Márián et al., 2003; Krasznai et al., 2006) . Akiyama et al., 1985; Shen et al., 1986) , the human ovarian carcinoma cell lines (A2780AD (Pgp + ) and A2780 (Pgp -); Louie et al., 1986 ) and the NIH 3T3 mouse fibroblast cell line and its human mdr1-transfected counterpart (NIH 3T3 MDR1 G185; Brugemann et al., 1992) were grown as monolayer cultures at 37°C in a 95% humidified air, 5% CO2
atmosphere. The cell lines were maintained in 75 cm 2 flasks in Dulbecco's modified Eagle's medium (DMEM) containing 4.5 g/l glucose and supplemented with 10% heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine and 25 µM/ml gentamycin. The KB-V1 cells were cultured in the presence of 180 nM vinblastine. The A2780AD and NIH 3T3 MDR1 cells were cultured in the presence of 2 µM and 670 nM doxorubicin, respectively. The cells were trypsinized two-three days before the experiments and maintained without drugs until harvesting them at the upper 2/3 part of the log phase. The cell viability was always higher than 90%, as assessed by the trypan blue exclusion test.
Membrane preparation
The NIH 3T3 MDR1 G185 human mdr1-transfected mouse fibroblast cells obtained from Michael Gottesman's laboratory (National Institutes of Health, Bethesda, MD) were harvested by scraping them into phosphate buffered saline (PBS, pH=7.4) and washed twice.
Membrane preparation was carried out according to (Sarkadi et al., 1992) with minor modifications. The cells were lysed and homogenized using glass-Teflon tissue homogenizer in TMEP (50 mM Tris, pH 7.0, 50 mM mannitol, 2 mM EGTA, 0.5 mM phenylmethylsulfonyl fluoride, and protease inhibitor cocktail (Sigma P2714)), then the undisrupted cells and nuclear debris were removed by centrifugation at 500 × g for 10 min.
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The supernatant was centrifuged for 60 min at 28,000 × g and the pellet containing the membranes was resuspended in TMEP. All procedures were carried out at 4 °C, and the membranes were stored at -70 °C until use.
ATPase assay
ATPase activity of the isolated NIH 3T3 MDR1 cell membranes was estimated by measuring inorganic phosphate liberation (Sarkadi et al., 1992) . Membrane suspensions containing 5 µg membrane protein were preincubated in 60 µl ATPase assay mix (50 mM MOPS, 65 mM KCl, 6.5 mM NaN 3 , 2.6 mM DTT, 1.28 mM oubain, 0.65mM EGTA, adjusted to pH 7.0 with Trisma-base) in the presence or absence of 100 µM Na 3 VO 4
(vanadate) at 37 °C. The assay mix also contained the studied agent at different concentrations and 40 µM verapamil as stimulator agent in the stimulated samples. 
Radiotracers
The glucose analog 2-deoxy-2-[18F]fluoro-D-glucose ( 18 FDG) was synthesized and labeled with the positron-decaying isotope 18 F according to Hamacher et al. (Hamacher et al., 1986) . The synthesis was performed on a commercially available GE Tracerlab FX FDG module. The radiochemical purity of 18 FDG was better than 99 %. The specific activity of 18 FDG was 27±6.5 GBq/µmol.
log P (octanol/water partition coefficient) determination
The determination of log P value was performed as we described earlier (Márián et al., 2005) . Half milliliter of octanol was added to a centrifuge tube containing 0.5 ml of PBS + 5 µCi (0.185 MBq) 18 FDG. The mixture was shaken intensively for 20 minutes and the tubes were centrifuged at 1000 × g for 20 min. The radioactivities of the octanol and water phases
were measured with a calibrated Canberra Packard gamma counter. The log ratio of the 18 FDG concentrations in the octanol and water phases was calculated.
In vitro radiotracer uptake and efflux studies of cancer cells measured in cell suspension
The cells were washed and resuspended in PBS containing 1 mM glucose (gl-PBS).
The samples were preincubated at 37 °C for 10 min at a cell concentration of 1 × 10 6 ml −1 in PBS. 10 μCi (0.37 MBq)/ml 18 FDG was then added to each sample. After the addition of the radioligand, cells were further incubated at 37 °C for 30 min. After these steps the control samples ( 18 FDG accumulation for 30 min) were washed 3 times with ice-cold PBS and resuspended in 1 ml of cold PBS, and the radioactivity was measured.
For the investigation of 18 FDG efflux the samples were first loaded with 18 FDG (at 37 °C for 30 min) and then washed with gl-PBS at room temperature. After centrifugation the supernatant was removed and the cells were resuspended in 2 ml 37°C gl-PBS and further incubated at 37 °C for 10-30 min. The efflux was terminated by the addition of ice-cold PBS.
The cells were then washed twice with ice cold PBS and the radioactivity was measured in a Canberra Packard gamma-counter for 1 min within the 18 F-sensitive energy window. Decaycorrected radiotracer uptake was expressed as counts min −1 (10 6 cells) −1 (cpm). The displayed data are the means of at least three independent experiments (± SD) carried out using different cell passages, and each experiment was performed in triplicate.
In vitro 18 FDG uptake and efflux of cancer cells measured in monolayer, using a miniPET camera
The Pgp + and Pgp -cell pairs were cultured (0.4-0.5 × 10 6 cells in 2 ml culture medium)
in Petri dishes (40 × 11mm) for 24-30 hours. By the end of the culture period the cells were grown in monolayer and covered 70-80% of the Petri dishes. Before the 18 FDG uptake studies the cell cultures were washed with 2 ml DMEM containing 1mM glucose (gl-DMEM). After washing, the cells were incubated with 100 µCi (3.7 MBq)/2 ml 18 FDG for 30 minutes in gl-DMEM at 37°C in a 95% humidified air, 5% CO 2 atmosphere. Thereafter the samples were washed twice at room temperature. Following that 2 ml gl-DMEM was added to each sample and the 18 FDG uptake was determined by the MiniPET-II scanner (Lajtos et al., 2013) . 2 min acquisition time was used. After the first PET scans the samples were incubated for other 30
or 60 minutes at 37°C in a 95% humidified air, 5% CO 2 atmosphere. After the incubation time the supernatant (medium) was discarded and 2 ml gl-DMEM was added to each sample. The retained 18 FDG was determined by the MiniPET-II scanner, using the same acquisition time (2 min). After the PET scans the cells were trypsinized, resuspended in PBS and the cell 11 numbers were determined. The viability of the cells used in our experiments was always higher than 90%, as assessed by the trypan blue exclusion test. All experiments were carried out using different cell passages and the means (±SD) of at least three independent experiments are given.
2.8.

FDG-PET data analysis
Ellipsoidal 3-dimensional regions of interest (ROI) were manually drawn around the edge of the tissue culture dish using BrainCad software (http:/www.minipetct.hu). The 18 FDG uptake was expressed in Bq/ml.
Indirect immunofluorescence
Formaldehyde (1% in PBS) prefixed cells were centrifuged at 500 × g for 5 min and 
Results
Distribution of 18 FDG between the octanol and water phase
We determined the distribution of the 18 FDG between the aqueous and octanol phases and found that the log P value was -2.018±0.03 (n=9) supporting its hydrophilic character. 
Effect of FDG and its metabolites on the R123 uptake of Pgp expressing cells
Effect of FDG on the ATPase activity of Pgp
R123 accumulation assays carried out with intact cells imply that the exact intracellular concentration of FDG and its derivatives is determined by glucose transport mechanisms and consequently is not equal to the extracellular concentration. Thus, we switched to ATPase activity measurements using membrane samples (containing predominantly inside-out vesicles or unsealed membranes), where the concentration of FDG and its derivatives in the aqueous phase is equal to the applied concentration. Since Pgp is an ATP driven active transporter, ATPase activity is required to fuel transport activity. In addition, similarly to several other ABC transporters Pgp also has a basal ATPase activity which can be observed in the absence of treatments with Pgp substrates (black circles), while addition of transport substrates e.g. verapamil stimulates the ATPase activity of the pump in a concentration dependent manner (Fig. 1a) . The maximal stimulation of the ATPase activity is between 2 to 10 fold depending on the substrate. Co-treatment with competitive Pgp inhibitors e.g. cyclosporin A decreases the verapamil stimulated ATPase activity in a concentration dependent manner (Fig. 1b) . Applying the same method we measured the effect of different 2-deoxy-glucose derivatives 2-fluoro-deoxy-glucose (FDG, Fig. 1c ), 2-chloro-2-deoxy-glucose (Fig. 1d) , 2-deoxy-D-glucose (Fig. 1e ) and 2-deoxy-D-glucose-phosphate (Fig.   1f ) on the basal and the substrate stimulated ATPase activity of Pgp. None of these agents had any effect on the basal or the 50 µM verapamil stimulated ATPase activity of Pgp, suggesting that these agents are not substrates or inhibitors of Pgp. (Fig. 2) . The glucose transporter expression was detected by means of indirect immunofluorescence using monoclonal antibodies and normalized to that of the isotype control. The ratios of the mean fluorescence intensities of the Pgp + /Pgp -were calculated. All of the examined protein expressions were slightly higher in the Pgp + cells, but these differences were not significant at p ≤ 0.05.
Pgp, glucose transporter and hexokinase-II expression
3.5.
FDG accumulation and washout kinetics measured in cell suspension and monolayer
The 18 FDG uptake and washout kinetics of the Pgp + and Pgp -cell line pairs were measured both in suspension and in monolayer (Fig. 3) . The 18 FDG uptakes of all three Pgp + cells were significantly higher (p ≤ 0.01) measured both in suspension and in monolayer than that of their Pgp -counterparts after 30 min incubation time, except the 3T3MDR1/3T3 cell pairs measured in monolayer (Fig. 3a) . The 18 FDG accumulation rate in the KB-V-1 and A2780AD cell lines was significantly higher (p ≤ 0.01) compare to their Pgp -counterparts (KB-3-1, A2780) when measured in suspension than when it was measured in monolayer, except the 3T3MDR1/3T3 cell pairs measured in suspension and monolayer (Fig. 3a) .
Although the washout kinetics of 18 FDG in the Pgp + cell lines were moderately faster, than that of their Pgp -pairs measured in suspension (both after 10 and 30 min. incubation time) the differences generally were not significant. However, significant differences were found in the retained 18 FDG fractions measured in suspension after 30 min washout time (see Fig. 3b) between the Pgp + and Pgp -KB cells (p = 0.04), and in case of the A2780 cell line pair (p = 0.065).
Similar tendency was obtained using adherent monolayer cultures but the differences between the Pgp + and Pgp -cell lines were even less (Fig. 3c ), and were not statistically significant.
Discussion
Currently 18 FDG is the most important PET radiotracer used in routine clinical cancer imaging, from diagnosing the malignancy to measuring its response to chemotherapy and/or radiation therapy in a wide range of human cancers including gynecologic tumors (Vallabhajosula, 2007; Kitajima et al., 2011) .
Several authors reported that the accumulation of 18 FDG differs between Pgp expressing and non-expressing cancer cells and tumors (Lorke et al., 2001; Márián et al., 2003; Higashi et al., 2004; Yamada et al., 2005; Krasznai et al., 2006; Seo et al., 2009; Krasznai et al., 2010; Smith, 2010) . A number of them accounted decreased accumulation of 18 FDG in cancer cells and tumors expressing Pgp at high level (Lorke et al., 2001; Higashi et al., 2004; Yamada et al., 2005; Seo et al., 2009; Smith, 2010 , Yu et al., 2012 . The most obvious interpretation of this observation would be that 18 FDG is a substrate of Pgp.
However, there are no exact experiments available in the literature up till now supporting this assumption. The aim of this study was to investigate whether the 18 FDG and its metabolites are substrates or modulators of Pgp.
Pgp is an ATP-dependent drug efflux pump exhibiting extremely wide substrate spectrum. It exports structurally unrelated compounds out of cells at the expense of ATP hydrolysis, keeping intracellular levels of chemotherapeutics below a toxic threshold. Pgp is referred as a "hydrophobic vacuum cleaner", because it is believed to extract its substrates directly from the inner leaflet of the plasma membrane (Homolya et al., 1993; Ling, 1997, 1998) . In accordance with it Pgp substrates are hydrophobic substances (Sarkadi et al., 1994) with logP values in the range of 2 to 5. For instance the logP value of verapamil is 3.78 (Buchwald and Bodor, 1998) , and a competitive Pgp inhibitor cyclosporin A has a log P value of 2.92 (el Tayar et al., 1993) . We found that the logP value of 18 FDG is -2.02, which demonstrates its hydrophilic character and does not support its direct interaction with Pgp as a substrate or modulator.
In R123 accumulation assay competitive inhibitors of Pgp (verapamil and CSA) increased the dye uptake of the Pgp + cells, while FDG and its derivatives did not have any effect (Table 1) . To further test whether FDG is a substrate or modulator of Pgp we carried out ATPase activity measurements. Pgp exhibits a high-capacity substrate-dependent ATP hydrolytic activity that is a direct reflection of its substrate transport capability (Scarborough, 1995) . Substrates readily stimulate the ATPase activity of Pgp, while competitive inhibitors bind tightly to the drug-binding site inhibiting substrate transport as well as ATP hydrolysis.
We found in our ATPase assay that FDG does not affect the ATPase activity of Pgp ( Fig. 1 ) further supporting that it is not a substrate or inhibitor of the transporter. FDG is converted to FDG-6-P very rapidly (Kaarstad et al. 2002) . FDG-6-P is not commercially available, therefore we used the 2-deoxy-glucose-6-phosphate in our experiments, which has very close chemical characters to that of the FDG-6-P molecule and found that it does not have any influence on the ATPase activity of Pgp. Collectively, these results strongly suggest FDG uptake into the tumors (Wahl, 1996; Vallabhajosula, 2007; Smith, 2010; Breier et al., 2013) . In line with the above assumptions numerous studies compared the level of GLUT transporters, the hexokinase activity and the 18 FDG accumulation of different tumor cells. Several authors reported strong positive correlation between the GLUT transporter expression, the 18 FDG uptake and the malignancy of tumors, while others found only weak correlations (Lorke et al., 2001; Zhao et al., 2005; Smith et al., 2007; Vallabhajosula, 2007; Ong et al., 2008; Paudyal et al., 2008; Seo et al., 2009; Smith, 2010; ) . Zaho et al. (2005) and Yu et al. (2012) demonstrated that the intratumoral 18 FDG distribution correlates well with the expression levels of GLUT-1, GLUT-3, and Hexokinase-II. In line with the above Southworth et al. (2003) suggested tissue specific differences in the phosphorylation rate of 18 FDG to 18 FDG -6-phosphate. The elevated expression levels of GLUT-1, GLUT-3, and HK-II, induced by hypoxia (HIF-1α), may be also be contributing factors to the higher 18 FDG accumulation in the tumor region. Hypoxic conditions linked to an increase in HIF-1α expression may affect the expression and transport function of Pgp as well (Breier et al., 2013) . In contrary, Seo et al. (2009) Fig. 2 and Fig. 3a) .
Interestingly, we measured significantly higher 18 FDG accumulation in the Pgp + cell lines compared to their Pgp -counterparts (Fig. 3a) , in agreement with our previous results (Márián et al., 2003 (Márián et al., , 2005 Krasznai et al., 2006) . Pgp is a transport ATPase with high basal 20 ATPase activity that is further increased in the presence of substrates (see Fig. 1 (Márián et al., 2000) .
In efflux measurements we observed slightly faster 18 FDG efflux from the Pgp + KB-V-1 and A2780AD cells compared to their Pgp -counterparts ( Fig. 3b and c) . Since the elevated efflux rate was measured in those cells that accumulated the highest amount of 18 FDG (Fig. 3a) , it is probably explained by an increased production of the dephosphorylated 18 FDG by the glucose-6-phosphatase enzyme and its concomitant transport by glucose transporter molecules. 
Figure legends
